Navigation Links
MedImmune's Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
Date:8/23/2007

GAITHERSBURG, Md., Aug. 23 /PRNewswire/ -- MedImmune, Inc. today announced that in a Phase 3 study, motavizumab was shown to reduce hospitalizations due to respiratory syncytial virus (RSV) by 83 percent as compared to placebo (8.3 percent in placebo arm vs. 1.4 percent in motavizumab; p<0.001), as the trial's primary endpoint. In addition, the trial showed a 71-percent reduction in the incidence of RSV-specific lower respiratory infections (LRIs) requiring outpatient management (9.5 percent in placebo group and 2.8 percent in the motavizumab group; p<0.001), which was a secondary endpoint.

Motavizumab is an investigational monoclonal antibody (MAb) being evaluated for its potential to prevent serious disease caused by RSV in high-risk pediatric patients. This Phase 3 trial involved 1,410 full-term infants less than six months of age in two Native American populations. In previous medical studies these populations were shown to have high rates of hospitalization due to RSV.

The randomized (2:1), double-blind study was designed to compare monthly intramuscular injections of motavizumab against placebo. After an interim analysis conducted by an independent data safety monitoring committee, the study was unblinded early due to statistical evidence demonstrating that motavizumab reduced RSV hospitalizations and LRIs requiring outpatient medical management within this population. Kate O'Brien, M.D., associate professor at the Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, served as the study's principal investigator.

"We are pleased with the results of this study which support the positive results seen in our Phase 3 pivotal trial comparing motavizumab and Synagis(R) (palivizumab) that were previously reported at the Pediatric Academic Societies meeting in May 2007," said Genevieve Losonsky, M.D., vice president, clinical development, infectious disease, MedImmune.

Motavizumab was well tolerated in these
'/>"/>

SOURCE MedImmune, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
2. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
3. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
4. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
5. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
6. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
7. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
8. Pivotal Phase III Trial Showed Promacta (eltrombopag olamine) Raised Platelet Counts and Reduced Bleeding in Patients With Chronic ITP
9. Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have Reduced Potential to Develop Resistance to Panacos Bevirimat
10. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
11. Data Suggest Cymbalta Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... LAUSANNE , Switzerland , September ... Genetics, leader européen de la médecine basée sur les ... son premier contrat avec le National Health Service au ... Cela fait suite à une forte hausse de la ... cliniques émanant des laboratoires et hôpitaux en Allemagne, en ...
(Date:9/12/2014)...  WellStar Paulding Hospital is the first hospital in ... in the U.S. to offer a new, innovative procedure ... System, Paulding Hospital is on the cutting edge of ... Inspire Therapy offers relief for moderate to ... to use traditional treatments, like Continuous Positive Airway Pressure ...
(Date:9/12/2014)... , Sept. 12, 2014 ... of the "Global Medical Technologies Market 2014-2018" ... Medical technology is a collective term for software ... to ensure good health. The Global Medical Technologies ... and respiratory technology, In vitro diagnostics technology, dental ...
Breaking Medicine Technology:Sophia Genetics annonce son premier contrat avec le National Health Service britannique et un grand laboratoire turc, élargissant ainsi sa clientèle européenne 2WellStar Pioneers New Sleep Apnea Treatment 2Global Medical Technologies Market 2014-2018: Key Vendors are GE, Johnson & Johnson, Medtronic, Roche and Siemens 2Global Medical Technologies Market 2014-2018: Key Vendors are GE, Johnson & Johnson, Medtronic, Roche and Siemens 3
... Transgenomic, Inc. (OTC/BB: TBIO) today announced the ... Results and Business Update Conference CallWhen: , Thursday, August ... How: , Live over the Internet -- Simply log ... Investor Relations, 402-452-5400To access the call via telephone, call ...
... 11, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: ... pharmaceutical and biotechnology research and development outsourcing company, today ... two multi-staged projects in its biologics division, which portends ... The initial milestones were achieved for two oncology ...
Cached Medicine Technology:Transgenomic to Hold Second Quarter Financial Results Conference Call Today 2ShangPharma's Biologics Division Announces Accelerated Achievement of Milestones for Two Multi-Stage Projects 2
(Date:9/14/2014)... Top10BestSEOHosting.com always offers truly reliable information for ... carefully, the site has announced that Arvixe ( ... WordPress Hosting suppliers in the current market. , ... hosting provider, and the company’s reputation for reliability ... known for its flexible hosting packages, decent uptime ...
(Date:9/14/2014)... September 14, 2014 Final Cut Pro ... the production of the Flip Flop Theme template for ... Flop is a simple-to-use and simplistic template that allows ... ease in Final Cut Pro X," said Christina Austin, ... and On-Screen controls, the user has controls of the ...
(Date:9/13/2014)... Recently, an experienced supplier of wedding ... its new collection of eggplant evening dresses . ... discounted rates, up to 58% off. According to the ... September 23. , The company’s new items are ... vintage, plus size, modest, sexy outfits and so on. ...
(Date:9/13/2014)... Ticket Down is a dependable ... beloved pop-rock group that originally formed in 1994 in Los ... of the group had been anticipating a new album since ... excited yet about the release of their new album, they ... a massive worldwide tour beginning in the United States in ...
(Date:9/13/2014)... (PRWEB) September 13, 2014 MillionaireSinglesDating.com ... by Successful Match, the leading niche dating services ... site PositiveSingles.com, the leading sugar daddy site ... site , InterracialMatch.com. The site has recently reached ... millionaire singles and admirers. The members include CEOs, ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com: The Best Linux Web Hosting Suppliers Now Unveiled 2Health News:Pixel Film Studios Releases Flip Flop Theme for Final Cut Pro X Users 2Health News:Cheap Eggplant Evening Dresses Now Announced By Experienced Company iFitDress.com 2Health News:Maroon 5 Tickets Now on Sale in Philadelphia, Washington DC, Nashville, San Jose, Chicago, Dallas, Los Angeles, Tacoma, Saint Paul, Vancouver, San Diego & New York 2Health News:Maroon 5 Tickets Now on Sale in Philadelphia, Washington DC, Nashville, San Jose, Chicago, Dallas, Los Angeles, Tacoma, Saint Paul, Vancouver, San Diego & New York 3Health News:MillionaireSinglesDating.com Reaches 2 Million Users Milestone 2
... Adults with type 2 diabetes who eat unhealthy, ... this can be offset by taking antioxidant vitamins with ... There is already growing evidence linking diabetes to cognitive ... are especially vulnerable to acute meal-induced memory deficits after ...
... Form 10-Q,s for First Three Quarters of Fiscal 2008 ... for Fiscal 2008 Ended March 31, 2008 Points to ... ... ST. LOUIS, June 25 KV Pharmaceutical Company,(NYSE: KVa/KVb), a ...
... in Oral Biology Award will be presented to Dr. ... Pediatric Dentistry, University of Alabama at Birmingham School of ... for Dental Research (IADR) at its 86th General Session ... Dr. Childers, research has contributed to the understanding of ...
... Canada As part of the Opening Ceremonies of ... Metro Toronto Convention Centre, the International Association for Dental ... follow: , IADR Honorary Membership ... may select an Honorary Member who has made significant ...
... N.C., June 25 New research that explores,the tactics ... management is now available in the Best Practice Database, ... Best,Practices, LLC., To review sample key findings and ... with links to each study at this address:, http://www3.best-in-class.com/dr319.htm ...
... there,s a new infant formula that blocks transmission of ... status during pregnancy will affect her baby,s future dental ... prevents early-childhood tooth decay? ,These are but a few ... be presented when the International,Association for Dental Research (IADR) ...
Cached Medicine News:Health News:Seniors with type 2 diabetes may experience memory declines immediately after eating unhealthy meal 2Health News:Seniors with type 2 diabetes may experience memory declines immediately after eating unhealthy meal 3Health News:KV Pharmaceutical Company Completes Fiscal 2008 Filings With Securities and Exchange Commission 2Health News:KV Pharmaceutical Company Completes Fiscal 2008 Filings With Securities and Exchange Commission 3Health News:KV Pharmaceutical Company Completes Fiscal 2008 Filings With Securities and Exchange Commission 4Health News:International Association for Dental Research presents awards and fellowships 2Health News:International Association for Dental Research presents awards and fellowships 3Health News:International Association for Dental Research presents awards and fellowships 4Health News:International Association for Dental Research presents awards and fellowships 5Health News:Best Practice Database Adds Research on New Product Commercialization 2Health News:International Dental Research Association meets in Toronto 2Health News:International Dental Research Association meets in Toronto 3Health News:International Dental Research Association meets in Toronto 4
PDA-version of the leading portable drug reference....
PDA formatted guide containing outlines and detailed information on the diagnosis and treatment of HIV infection and AIDS....
PDA application contains 15,000+ ICD-9-CM Diagnosis codes....
Information on diagnosis and management of 500 common or important medical and surgical disorders....
Medicine Products: